Mohs Micrographic Surgery and Its Utility in High-Risk Non-Melanoma Skin Cancer - Enduring

City of Hope currently does not have a Mohs Micrographic Surgeon on staff at our center, with many skin cancers sent to other surgical subspecialties. Mohs Micrographic Surgery (MMS) is a surgical technique that can only be performed by a dermatologist who has done a MMS fellowship.  MMS is performed on larger, high-risk cancers as well as those in cosmetically sensitive areas. MMS is the only surgical technique that examines 100% of the margin of tumor, is 99% effective (the high cure rate), and removes skin cancer with the smallest scar possible, sparing healthy tissue. Ideal practice is the referral of most high-risk, cosmetically sensitive skin cancers to a Mohs surgeon. Typically, skin cancers are referred to dermatology for biopsy for diagnosis.  From there, the definitive therapy is determined by a dermatologist (radiation vs. type surgery vs. skin-directed chemotherapy).  At our institution, we frequently have skin cancers referred from oncology or hematology to a surgical subspecialty.  In doing this, we are not considering all therapies.  In particular MMS gets overlooked, more so, because we do not have a MMS trained surgeon at our institution.  Our physicians and Advance Practice Providers should be aware that this technique exists due to the high skin cancer burden among our patient population, particularly in those who have undergone transplant.

Target Audience

Physicians and Advanced Practice Providers.

Learning Objectives

  • Identify patients in which high-risk skin cancers are a barrier to further needed immune suppressive care.
  • Assess the various surgical techniques utilized to remove skin cancers and stage them appropriately.
  • Examine the importance of the Mohs micrographic technique from a surgical and a pathologic perspective.
  • Outline the various types of cultural diversities (gender, age, race, religion, culture, etc.) that relate to demographics, diagnosis and treatment.
Activity summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
    City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
    City of Hope designates this Mohs Micrographic Surgery and Its Utility in High-Risk Non-Melanoma Skin Cancer - Enduring for a maximum of 1.00 AMA PRA Category 1 Credit™ requirements. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Attendance
Activity opens: 
06/04/2021
Activity expires: 
06/04/2022
Internet
United States

This activity has been planned and implemented in strict compliance with the accreditation requirements, standards, and policies of the ACCME. City of Hope takes responsibility for the content, quality and scientific integrity of this CME activity.

As an accredited CME provider City of Hope requires everyone who is in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 24 months, including financial relationships of a spouse that could create a conflict of interest. Any potential conflicts relative to the previous disclosure have been resolved.

Presenter: Dr. Jenny Hu has indicated that she is a Consultant for Regeneron Pharmaceuticals.

City of Hope further encourages faculty/ authors to identify investigational products or off-label uses of products regulated by the U.S. Food and Drug Administration, at first mention and where appropriate in the content.

The information and opinions presented in this activity do not constitute medical or legal advice. Health care providers must exercise their own professional judgment in their clinical practice, and when confronted with the issues discussed herein, should not substitute this curriculum for the advice of legal counsel or application of sound ethical principles.

Mohs Micrographic Surgery and Its Utility in High-Risk Non-Melanoma Skin Cancer - Enduring has received no commercial support.

ACCREDITATION STATEMENT: City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION: City of Hope designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

The following credit type(s) are being offered for this course:

•  AMA PRA Category 1 Credit™  1.0

The following may apply AMA PRA Category 1 Credit™ for license renewal:

Registered Nurses: Nurses may report up to 1.0 credit hours toward the continuing education requirements for license renewal by their state Board of Registered Nurses (BRN). AMA PRA Category 1 Credit™ may be noted on the license renewal application in lieu of a BRN provider number.

Physician Assistants: The National Commission on Certification of Physicians Assistants states that AMA PRA Category 1 Credit™ accredited courses are acceptable for CME requirements for recertification.
 

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
    City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
    City of Hope designates this Mohs Micrographic Surgery and Its Utility in High-Risk Non-Melanoma Skin Cancer - Enduring for a maximum of 1.00 AMA PRA Category 1 Credit™ requirements. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Attendance
Please login or register to take this activity.

You must be logged in to access this Enduring. 

If you are a New User, please create an account first, by clicking on "Register". 

Once Logged in: 

Click on "Start Activity" to access the educational content for this Enduring activity.

Required Hardware/software

Current version of Edge, Firefox, Safari, or Chrome.